After many years of trying, Wyeth has received approval and is currently marketing the newest antidepressant in the US -- desvenlafaxine. What do you need to know about this medicine? Host Dr. Leslie Lundt welcomes Dr. Philip Ninan, vice president for Neuroscience Global Medical Affairs at Wyeth Pharmaceuticals to discuss the ins and outs of desvenlafaxine.